According to multiple media reports, Adar Poonawalla, the CEO of Serum Institute of India, was in negotiations with Diageo Plc, the owners of Royal Challengers Bengaluru (RCB), to potentially purchase the Indian Premier League's (IPL) 2025 champion. Whether Diageo Plc intends to sell all of its shares in
👨💻StartupTalkers
India’s biotechnology industry is moving towards new leaps and bounds keeping with the pace of global development. The main concentration of the biotech industry is biopharmaceuticals as India is one of the largest manufacturers of generic drugs. Adar Poonawalla one of the leading businessmen of India and the chief
📄Company Profiles
Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations. The content in this post has been approved by Serum Institute of India. India has reported more than 19 million cases since the pandemic started, second only to the United States. There have also
👨💻StartupTalkers
Cyrus Poonawalla is an Indian businessman and Philanthropist who is the Chairman of Cyrus Poonawalla Group, which includes the Indian biotech company [https://startuptalky.com/top-biotech-startups-india/], Serum Institute of India. He is also known as "vaccine king of India", because his firm manufactures pediatric vaccines and contributes towards
🔍Insights
India started its vaccination programme for Covid-19 on 16 January 2021. The vaccination was first prioritized for frontline and healthcare workers. The Covishield vaccine and Covaxin have been approved by the government. There are many more companies working behind developing the vaccine in the country. Serum Institute of India Bharath